Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOcado Regulatory News (OCDO)

Share Price Information for Ocado (OCDO)

Share Price is delayed by 15 minutes
Get Live Data
205.00    5.10 (2.55%)
Bid:
205.60
Ask:
207.20
Spread: 1.60 (0.778%)
Market Cap: £1.71b
OCDO Live PriceLast checked at - London Stock Exchange

Intraday Ocado Share Chart

Update on Financing Transaction

14 Jun 2017 15:52

RNS Number : 1093I
Ocado Group PLC
14 June 2017
 

OCADO GROUP PLC

 

14 June 2017

Successful Upsizing and Pricing of £250 million Senior Secured Notes due 2024

Further to the announcement of 12 June 2017, Ocado Group plc ("Ocado") today announces that it has successfully priced an offering of £250,000,000 Senior Secured Notes due 2024 at a coupon of 4% ("the Offering") and an issue price of 100%. Due to strong demand the Offering was upsized from the originally anticipated size of £200,000,000. The Offering is expected to close on 19 June 2017. On closing the Offering, Ocado expects to complete the amendment and extension of its Revolving Credit Facility with final commitments of £100,000,000 which has been reduced proportionately to the upsizing of the Offering (together with the Offering, the "Financing Transactions").

 

These Financing Transactions will extend the maturity profile of Ocado's debt and diversify our sources of funding as well as increase the overall level of funding available to Ocado to grow the business. As a result of its continued strong trading, increased scale and profitability, Ocado has benefitted from the historically low financing costs in the public debt markets to put in place longer maturity financing on attractive terms. The proceeds of the Offering will support the continued growth of Ocado's UK retail capacity, and further improvements to our proprietary platform, and will also be used to repay existing debt under Ocado's Revolving Credit Facility and retire certain finance lease obligations.

 

Contacts

Duncan Tatton-Brown, Chief Financial Officer, on 01707 228 000

David Hardiman-Evans, Head of IR & Corporate Finance, on 01707 228 000

Michelle Clarke or Susanna Voyle, Tulchan Communications, on 020 7353 4200

 

Financial Calendar

Ocado's financial reporting calendar for the remainder of the year will be a Half Year Results Statement on 5 July 2017, a Q3 Trading Statement on 19 September 2017 and a Q4 Trading Statement on 14 December 2017. 

 

Important Information

NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA.

Certain statements made in this announcement are forward-looking statements. Such statements are based on current expectations and assumptions and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially from any expected future events or results expressed or implied in these forward-looking statements. Persons receiving this announcement should not place undue reliance on forward-looking statements. Unless otherwise required by applicable law, regulation or accounting standard, Ocado does not undertake to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

These materials are not an offer of securities for sale in the United States. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States. Any securities sold in the United States will be sold only to qualified institutional buyers (as defined in Rule 144A under the Securities Act) pursuant to Rule 144A. Any decision to invest in the notes offered in the Offering must be made solely based on the information in the Offering Memorandum.

This announcement is for informational purposes only and is directed only at persons who are: (a) persons in member states of the European Economic Area (the "EEA") who are qualified investors (as defined in EU Prospectus Directive 2003/71/EC (as amended, including by EU Directive 2010/73/EU to the extent implemented in the relevant member state)); (b) persons in the United Kingdom who are qualified investors and who are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) persons falling within Article 49(2) (a) to (d) of the Order ("high net worth companies, unincorporated associations, etc."); or (iii) persons to whom an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any senior secured notes may otherwise be lawfully communicated or cause to be communicated (all such persons in (a) and (b) together being referred to as "relevant persons"). This announcement must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

In connection with the offer of the above securities, the Stabilising Managers may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there can be no assurance that the Stabilising Managers will take any stabilisation action, and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBSGDLISBBGRS
Date   Source Headline
3rd Jun 202412:21 pmRNSTotal Voting Rights
21st May 20244:38 pmRNSDirector/PDMR Shareholding
16th May 202412:16 pmRNSDirector/PDMR Shareholding
9th May 20247:00 amRNSDirectorate Change
7th May 20243:43 pmRNSDirector/PDMR Shareholding
1st May 202410:26 amRNSTotal Voting Rights
29th Apr 20244:01 pmRNSResult of AGM
22nd Apr 20244:28 pmRNSDirector/PDMR Shareholding
15th Apr 20243:15 pmRNSDirector/PDMR Shareholding
15th Apr 202411:57 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSDirectorate Change
2nd Apr 20241:01 pmRNSDirector/PDMR Shareholding
2nd Apr 202412:01 pmRNSTotal Voting Rights
28th Mar 20242:50 pmRNSDirector/PDMR Shareholding
28th Mar 20242:45 pmRNSDirector/PDMR Shareholding
28th Mar 20242:27 pmRNSDirector Declaration
26th Mar 20247:00 amRNSTrading Statement
15th Mar 20245:25 pmRNSDirector/PDMR Shareholding
1st Mar 202411:31 amRNSTotal Voting Rights
29th Feb 20244:41 pmRNSNotice of AGM
29th Feb 20244:25 pmRNSAnnual Financial Report
29th Feb 20247:00 amRNSFinal Results
16th Feb 202411:26 amRNSDirector/PDMR Shareholding
5th Feb 20243:01 pmRNSHolding(s) in Company
2nd Feb 20249:16 amRNSBoard Changes
1st Feb 202410:24 amRNSTotal Voting Rights
29th Jan 20244:42 pmRNSBlock listing Interim Review
22nd Jan 202410:37 amRNSHolding(s) in Company
16th Jan 202411:23 amRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNSTrading Statement
3rd Jan 20242:26 pmRNSTotal Voting Rights
18th Dec 202312:08 pmRNSDirector/PDMR Shareholding
4th Dec 20233:54 pmRNSHolding(s) in Company
1st Dec 202310:36 amRNSTotal Voting Rights
29th Nov 20235:30 pmRNSDirector/PDMR Shareholding
29th Nov 202311:53 amRNSDirector/PDMR Shareholding
28th Nov 20234:51 pmRNSDirector/PDMR Shareholding
27th Nov 20237:15 amRNSDirector Declaration
16th Nov 20239:03 amRNSDirector/PDMR Shareholding
15th Nov 20233:38 pmRNSOcado announces deal with McKesson Canada
1st Nov 202310:32 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSDirector Declaration
30th Oct 20232:23 pmRNSDirector/PDMR Shareholding
17th Oct 20231:16 pmRNSDirector/PDMR Shareholding
16th Oct 20234:49 pmRNSAdditional Listing
6th Oct 20239:56 amRNSHolding(s) in Company
2nd Oct 202310:23 amRNSTotal Voting Rights
19th Sep 20237:00 amRNSTrading Statement
15th Sep 20232:06 pmRNSDirector/PDMR Shareholding
6th Sep 20231:58 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.